Clinical Trial Update: Trial of Novel Oral Zinc Cysteine Preparation in Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describes a Phase 1/Phase 2 study of a novel oral zinc cysteine preparation for Alzheimer's disease and mild cognitive impairment, spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Cognitive Impairment

Drugs mentioned

• Novel Oral Zinc Cysteine Preparation (Zinc cysteine complex)

Snippet

Sponsor: Adeona Pharmaceuticals | Conditions: Alzheimer's Disease, Mild Cognitive Impairment | Phase 1, Phase 2 | Status: UNKNOWN